Advertisement

Topics

University of Dundee and Boehringer Ingelheim collaborate for free access of PROTAC compound on opnMe.com

04:00 EST 9 Jan 2019 | Drug Discovery Today

Boehringer Ingelheim is to make the BET degrader compound MZ 1 available through its opnMe.com portal. The company actively supports open access in order to boost progress in biomedical and drug discovery research. MZ 1 (created at the University of Dundee) is the first external compound to be added to Boehringer Ingelheimā€™sā€™ opnMe.com portal.

Original Article: University of Dundee and Boehringer Ingelheim collaborate for free access of PROTAC compound on opnMe.com

NEXT ARTICLE

More From BioPortfolio on "University of Dundee and Boehringer Ingelheim collaborate for free access of PROTAC compound on opnMe.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...